Successful Treatment of a Patient With Multiple-Line Relapsed Extensive-Stage Small-Cell Lung Cancer Receiving Penpulimab Combined With Anlotinib: A Case Report

Small-cell lung cancer (SCLC) is a highly malignant, rapidly developing group of diseases with poor biological behavior. Most patients have extensive-stage SCLC (ES-SCLC) when they are first diagnosed. Standard chemotherapy is prone to relapse in a short period of time, and the patients’ median over...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zibo, Li, Yujun, Dong, Yan, Li, Jia, Zhang, Bin, Zhang, Chunxia, Cui, Xiaonan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8937034/
https://www.ncbi.nlm.nih.gov/pubmed/35321433
http://dx.doi.org/10.3389/fonc.2022.846597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8937034/
https://www.ncbi.nlm.nih.gov/pubmed/35321433
http://dx.doi.org/10.3389/fonc.2022.846597

Ejemplares similares